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ENVENOMING BY CORAL SNAKES (Micrurus) IN ARGENTINA  
DURING THE PERIOD BETWEEN 1979-2003
Adolfo Rafael de ROODT(1,2), Ernesto DE TITTO(3), Jorge Adrián DOLAB(4) & Jean-Philippe CHIPPAUX(5,6)
SUMMARY
Envenomation by coral snakes (Micrurus sp.) is one of the most dangerous injuries in America and it is considered as a serious 
medical emergency, however bites by these snakes appear to be rare. We analyzed epidemiological data, clinical signs and antivenom 
use in Argentina during the period between 1979-2003. During this period of study 46 non-fatal Micrurus bites were reported. The 
majority of cases were men from 31 to 40 years old. Bites occurred primarily in spring and summer. Most cases were reported from 
the northeast and northwest provinces of the country. The bites were mostly located on hands or feet and occurred mostly during 
agricultural activities and so mainly involved farmers. Only four cases occurred as a result of handling snakes. The median time it 
took for antivenom to be administrated was 60 minutes after the bite, and the median number of vials applied was 2. Local pain was 
mentioned and edema was reported in 41% of patients. All patients recovered without sequelae. This study showed a low incidence 
of Micrurus bites and low severity of envenomation. However, although no deaths have been reported during the last 30 years, given 
the toxicity of the venom of Micrurus snakes, the risk of severe envenomation should be considered.
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INTRODUCTION
Coral snakes are endemic in the Americas from the South of United 
States of America to the South of Argentina, in the Patagonian region. 
They represent a potential risk to human health throughout the continent.
Coral snakes belong to the Elapidae family which constitutes a 
taxonomic group of over 120 species and subspecies7, represented by the 
genera Micrurus, Micruroides and Leptomicrurus. Micrurus is the main 
genus, containing more than 70 species7, six of which can be observed 
in Argentina. The species described are Micrurus (M.) altirostris, M. 
balyocoriphus, M. corallinus, M. frontalis, M. lemniscatus and M. 
pyrrhocryptus 24.
Micrurus bites are less frequent than snakebites from Crotalinae 
in the Americas5,10,14,23,24,25,33,42. In Central America and Colombia less 
than 2% of all snakebites have been related to bites by Micrurus spp.5,8, 
while in Brazil coral snakes accounted for 0.65% (486 out of 75,312) 
of bites by venomous snakes in the period between 2001-2004, with 
no recorded deaths6. In the United States of America, bites by coral 
snakes (principally by M. fulvius) represent 3.6% of accidents involving 
indigenous venomous snakes, based on records from the last 20 years 
(911 coral snake bites from a total of 25,551 bites by venomous snakes 
in the period between 1983-2003)1, which equates to around 45 bites/
year; while another report accounts for 1254 bites by Micrurus in the 
period between 1983-200741, leading to 50 ± 31 bites per year, this is in 
the same range as previous report. 
Deaths occuring from Micrurus bites are uncommon. The fact that 
coral snake bites are rare is evidence of their reclusive nature, lack of 
aggressiveness, shyness and the low effectiveness of their venom delivery 
apparatus when compared to that of pit vipers29.
Micrurus bites produce a neurotoxic envenoming, which can lead to 
peripheral paralysis of respiratory muscles in animals and humans6,21,34. 
The neurological symptoms may involve 1) a block of the postsynaptic 
cholinergic receptor by toxic peptides called a-neurotoxins, e.g. M. 





) (called b-neurotoxins), in addition 
to postsynaptic blocking, e.g. M. corallinus; and/or 3) a combined 
action of a-neurotoxins and myotoxic PLA
2
, e.g. M. nigrocinctus and 
M. fulvius39,40. 
In some experiments cardiovascular15 and hemorrhagic activities 
were observed in a few coral snake venoms such as those of M. fulvius37, 
M. averyi3 and M. frontalis frontalis17. There are no reports of clotting 
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activity with plasma or fibrinogen in the venoms of South American coral 
snakes17. However, some South American Micrurus showed edema which 
induced inflammatory activity3 and increased capillary permeability36. 
Although local lesions are uncommon, some Micrurus venoms have 
shown experimental myotoxic effects in mice2,3,18.
While there are detailed clinical reports and summaries regarding 
envenoming by coral snakes (M. fulvius) in North America1,21,23,30,31, 
such information does not exist in South America, although some case 
reports have been published in the last few decades6,22,31. Despite the 
important material regarding envenomings by Micrurus in South and 
Central America and the characteristics of their venoms and antivenoms, 
we are still lacking detailed descriptions of clinical or epidemiological 
characteristics of coral snake envenoming.
This is an account of data collected from epidemiological reports 
submitted to national health authorities, regarding patients bitten by coral 
snakes during the last 25 years in Argentina.
METHODS
This study is a retrospective analysis of available information from 
the former national program for snakebites (PNO = Programa Nacional 
de Ofidismo) from January 1979 to December 2003. All patients that were 
described as having been exposed to a coral snake bite were included.
Information was recorded in regular data sheets used by the PNO 
to report the use of antivenoms. Data took into account patient age, 
sex, location where the accident occurred, date and circumstance of 
the accident (inside or outside home, at work, etc.), anatomical site of 
the Micrurus bite, and signs and/or symptoms recorded at the time of 
medical examination. It also recorded the time elapsed between the bite 
and the treatment, the amount of antivenom given to the patient, and the 
clinical evolution of the case.
Specific incidences were calculated according to the provincial 
population of Argentinean provinces and the demographic distribution 
of ages in 199120. The χ2 test was used to compare the results where 
necessary.
RESULTS
A total of 46 coral snake bites have been reported during the 25 
year period, i.e. an average of two bites per year. In 1995, eight bites 
were observed, the highest number of bites in a single year (Fig. 1). The 
seasonal distribution of Micrurus bites, showed the highest incidence 
from mid-spring (October) to autumn (April) (Fig. 2). As regards the 
geographical distribution, most of bites occurred in the Northwest 
Province while only one case was reported from Patagonia (Fig. 3). No 
deaths were recorded.
The age group most affected by snakebites was that of 31-40 years 
(34%), with males being most affected by snakebites (70%) (Fig. 4). The 
majority of bites occurred during working activities (44%) and in rural 
areas (55%). Only four illegitimate bites were related to snake handling.
Hands and feet were the most frequent anatomical site of the bites, 
accounting for 82% of all bites; with hands and forearms 45.6%, and 
feet and ankles 54.4%.
Interestingly, most patients presented local symptoms. Pain was 
present in 31 patients (68.9%) and edema was reported in 15 patients 
(33.3%). Other manifestations were rare: two patients reported burning 
(4.4%), while myalgia and arthralgia were reported in three (6.7%) and 
two (4.4%) cases respectively.
Systemic signs were described in few cases: dizziness, tachycardia, 
hypertension and sickness (one case each, 2.2%); paleness (two cases, 
4.4%), tremors (four cases, 8.8%), while dispnoea and/or respiratory 
difficulty were reported in four cases (8.8%).
All patients received antivenom, which was a mandatory part of 
filling in the PNO report form. However, in nine cases the antivenom 
administered was not the specific one. In the 36 cases in which the specific 
antivenom was used, the median of injected vials was two (minimum 
one, maximum eight). The mean time for antivenom to be administrated 
after the bite was 194 min (from 15 min to 48 hours), while the median 
time between the bite and the treatment was 60 minutes.
Fig. 1 - Annual occurrence of cases between 1979-2003.
Fig. 2 - Seasonal occurrence of Micrurus bites in Argentina.
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In all cases the antivenom used for treatment was the Antiveneno 
Micrurus from the National Institute for Production of Biologicals of the 
National Administration of Laboratories and Institutes of Health, “Dr. 
Carlos G. Malbrán”, depending of the National Ministry of Health. This 
was (and is) the only available antivenom for treatment of coral snakes in 
Argentina. The pharmaceutical is in liquid form, in 5 mL vials containing 
F(ab’)
2
 fragments of equine immunoglobulins. The neutralization is 1 mg 
or more of venom by mL of antivenom (which means at least 5 mg of 
venom neutralized per vial). The information on the antivenom used was 
included in the PNO sheets.
In some cases, antivenom was used in association with additional 
drugs: corticoids (32 cases, 71.1%), corticoids plus antihistamines (six 
cases, 13.3%), antitetanic toxoid (14 patients, 31.1%), antibiotics (seven 
patients, 15.6%) and analgesics in five cases (11.1%).
The duration of hospitalization ranged from one to four days. The 
outcome was good in all cases, without any sequels reported.
DISCUSSION
All Micrurus bites reported to the PNO in Argentina during the years 
1979 to 2003 were analyzed except two of them that had been recorded 
twice. Since 2004, case reporting to PNO has been irregular and so it 
was not possible to continue the analysis.
The scarcity of cases reported before 1990, could be explained by 
an irregular distribution of antivenoms and/or, by a more parsimonious 
management of snakebites, but any possible reasons are difficult to 
determine retrospectively. Considering that the annual incidence of 
snakebites in Argentina is about 1,000 bites a year12, the frequency of 
coral snake bites was very low, representing only 0.2% of total snakebites.
The geographical distribution was irregular and decreased from north 
to south, this variation was possibly due to the abundance of Micrurus, 
the human population density or, perhaps, human activities. The highest 
frequency of bites was recorded in four Northern provinces (Salta, 
Santiago del Estero, Formosa and Misiones), where 65% of accidents 
occurred. The risk gradually decreased going south to northern Patagonia, 
where only a single bite by Micrurus was reported in 25 years.
Taking into consideration the provinces where the accidents occurred, 
M. pyrrhocryptus was responsible for more than a half of the bites. 
However, no difference was observed in a clinical presentation of bites 
when M. pyrrhocryptus was involved compared to other species, even 
in the Misiones province where six different species of Micrurus are 
encountered (χ2 = 0.8887; p = 0.62).
Micrurus are not aggressive and often shy. Contrary to an erroneous 
reputation about Micrurus which states that they cannot bite because 
their mouth is too small and opens only slightly, coral snakes are able to 
bite and inoculate their venom. However, the amount of venom obtained 
from these snakes is low9,15,16,19,34. The yield of venom from Argentinean 
Micrurus is about 14 ± 6 mg per adult snake11 ranging from 1 mg in 
small specimens to more than 40 mg in very large snakes (de ROODT 
unpublished results), as is the case for most South American Micrurus. 
In addition, the very short and fixed fangs and the absence of a closed 
duct to inject the venom, reduce the effectiveness of venom inoculation 
in comparison to vipers. As a consequence, not all bites result in 
envenoming. Significant clinical symptoms are recorded in approximately 
40% of Micrurus bites reflecting venom inoculation30,32,33, which seems to 
be slightly lower than elapid envenomings reported from other continents 
where the incidence of clinical disorders is estimated at 50-60% in 
humans7,9. However, it is well known that even a venomous snake may 
inflict a dry bite6,35. It is also possible that the rapid management of 
patients, half of which are treated within one hour after the bite, could 
explain the absence of death and severe envenoming among patients of 
Argentina. Most of them did not show any systemic disorder. Only four 
patients presented respiratory symptoms that quickly disappeared after 
Fig. 3 - Geographical specific incidence according to Argentinean Provinces. 3.a. Number 
of cases of accidents by Micrurus in each province. 1 - Santiago del Estero (11 cases), 2 - 
Misiones (10 cases), 3 - Formosa (five cases), 4 - Córdoba (five cases), 5 - Salta (four cases), 
6 - San Luis (four cases), 7 - Catmarca (two cases), 8 - San Juan (two cases), 9 - Chaco, 
10 - Santa Fe, 11 - Corrientes, 12 - Neuquén (one case in each province). 3.b. Specific 
Incidence by province (cases/100,000 inhabitants). 1 - Santiago del Estero (1.63691), 2 - San 
Luis (1.39860), 3 - Misiones (1.26743), 4 - Formosa (1.25628), 5 - Catamarca (0.75758), 
6 - Salta (0.46189), 7 - San Juan (0.37807), 8 - Neuquén (0.25707), 9 - Córdoba (0.18070), 
10 - Corrientes (0.12563), 11 - Chaco (0.11905), 12 - Santa Fe (0.03579).
Fig. 4 - Specific incidence according to age distribution in the Argentinean population (the 
trend curve was based on a polynomial model).
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antivenom administration. In contrast, 70% of them showed local signs, 
which is consistent with observations published elsewhere28.
In this study, no deaths were observed. However, nearly 10% 
of patients had respiratory symptoms that could have lead to severe 
complications. The venom of the Argentinean Micrurus is as toxic as 
the venom of Micrurus that causes death in other countries13,19,26,34,38. In 
Brazil, a country with very similar characteristics regarding the fauna and 
snakebite epidemiology, Micrurus bites are also uncommon4,14,25,27,31 and 
usually mild6,9 representing about 0.4% of total snakebites with 0.36% 
mortality25, which is very consistent with our results.
During the period of study the treatment with antivenom was 
highly variable, ranging between 1-8 vials. However, recent official 
recommendations from the national authorities suggest the application 
of 10 vials24, as recommended by the Ministry of Health of Brazil25. 
No clinical trial has been conducted in Argentina so far and so until 
this is possible the recommended doses are those suggested in Brazil, 
because of their experience of such accidents. Although the population 
of Micrurus snakes is not identical, all the Micrurus species that inhabit 
Argentina can be found in the South of Brazil7,9,24,25. The number of 
vials recommended is the same, nevertheless, the neutralizing potency 
of Argentinean antivenom by vial could be lower than the Brazilian 
one, since the neutralization capacity of Argentinean antivenom during 
the period of study was of 5-10 mg per 5 mL vial (DOLAB J.A., 
unpublished data) versus 15 mg per 10 mL vial (at least 1.5 mg/mL) of 
the Soro Antielapídico produced by the Butantan Institute (Sao Paulo, 
Brazil). However, it is difficult to compare the potencies because of 
the different methods used for determining the neutralization of these 
antivenoms in both countries (i.e. type and characteristic of the venoms 
used for determination, challenge doses of venom, inoculation route of 
the experimental animals used for the assay, among others). Clinical trials 
are necessary in order to establish the optimal dose of the antivenom in 
Argentina. 
Our data were collected through the “Programa Nacional de 
Ofidismo”. This program relied upon cases being reported by health 
care professionals. As a routine passive surveillance system, an under-
registration of snake bite reports can be expected for many reasons. 
Among the potential reasons are: a lack of antivenom that leads to people 
doubting the usefulness of the surveillance system, a lack of health 
professionals for operational issues, or patients being unable to access a 
health center for antivenom therapy. 
Although this type of system has several weaknesses, because all 
cases of Micrurus bites hold potential for severe envenoming in this 
country, these accidents are always reported and given precedence over 
the lack of antidote, the provincial and national sanitary authorities are 
required to treat the case. Therefore the antivenom (there is only one 
producer in the country) is sent via sites of the Ministry of Health and 
after treatment, the surveillance sheets are completed and sent.
One issue that is impossible to solve is when patients do not access 
the health center for the antivenom treatment. This is possibly the key 
weakness in this notification system.
Another problem regarding the notification system, based on 
patient reports, is a possible over registration of cases where it is only 
a suspected Micrurus bite and not a confirmed diagnosis. We discarded 
all cases where there was evidently some doubt concerning the clinical 
data or where another type of snakebite was indicated. Nevertheless, 
false coral snake bites may be a cause of misdiagnosis. In Argentina 
there are several species of false coral snakes, such as the species of 
Lystrophis, Oxyrrhopus and Erythrolampus. The lack of experience 
and familiarity of health professionals regarding red, white and black 
color pattern combinations placed in rings, could cause a misdiagnosis 
or mistaking a colubrid snake as a coral “dry bite”. Although this is 
certainly a possibility, professionals in health centers where snakebites 
are common receive instructions regarding the identification of true 
coral snake or false coral snake, which would theoretically diminish 
diagnostical errors. However, although bites misdiagnosed as false coral 
snake bites could be present among the cases considered in our study, 
the regions and centers where cases occurred and cases were attended 
indicate to us a high likelihood that the diagnosis of coral snake bites 
can be relied upon.
Despite the aforementioned, the key symptoms described in 
coral snake envenoming are due to the main venom action, which is 
neurotoxicity. However, symptoms such as myasthenia, palpebral ptosis, 
diplopia, or blurred vision were not described in data sheets recorded. 
This could be attributed to the physicians attending the emergency 
room not completely filling the spaces for recording specific clinical 
symptoms (due to work overload) and only noting down the most obvious 
symptoms. Finally, the other possibility is that there was only a very 
slight envenomation by coral snake bite due to a low injection of venom 
in the cases reported.
We are currently using new systems of collecting data on accidents 
involving venomous animals, and modified epidemiological sheets. It is 
possible that these changes along with the improvement of communication 
systems from the peripheral centers (where the snakebites occur) and 
the central levels (which collect and analyze data), will improve our 
knowledge regarding the envenomation by venomous animals in general 
and by coral snakes in particular.
In Argentina, Micrurus bites are rare and cause very few severe 
envenomings. This may be due to a small amount of venom injected, 
or the small size of the animal, or because the venom apparatus and the 
limited ability of the venom glands do not allow an effective inoculation 
of venom. However, although no deaths have been recorded over the 
past 30 years, the toxicity of the venom is high and the risk of severe 
envenoming should be considered. The specific antivenom is available 
throughout the country and should be administered early in all patients 
suffering from envenoming after Micrurus bites.
RESUMO
Envenenamento por cobras corais na Argentina durante o período 
1979-2003
O envenenamento por corais (Micrurus sp.) é um dos mais 
perigosos na América e considerado uma emergência médica grave 
ainda que acidentes por estas serpentes pareçam raros. Analisamos 
dados epidemiológicos e clínicos e o uso de soro antiofídico, durante 
o período de 1979-2003. As comunicações indicam 46 acidentes por 
Micrurus, aproximadamente dois casos anuais, sem registro. A maioria 
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dos casos ocorreu em homens de idade entre 31 e 40 anos, principalmente 
no período de primavera e verão e provenientes do noroeste e nordeste 
do país. Os acidentes na sua maioria ocorreram em mãos e pés, durante 
atividades agrícolas envolvendo trabalhadores rurais. Apenas quatro 
acidentes foram relacionados a manejo dos animais. Em todos os casos 
analisados houve descrição de dor local e em 41% dos pacientes houve 
edema. Por paciente foram administradas, em média, duas ampolas. O 
tempo médio de aplicação do soro foi de 60 minutos. Em todos os casos 
a recuperação foi favorável sem presença de sequelas. Neste estudo foi 
possível observar uma baixa incidência de acidentes e baixa severidade 
nos envenenamentos. Apesar de que não aconteceram mortes nos últimos 
30 anos, dado a toxicidade do veneno das cobras corais, o risco de 
envenenamento severo deveria ser considerado.
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